The 3rd annual meeting of the American Academy of Nanomedicine (AANM) —Sept. 7-9 at the University of California, San Diego (UCSD)—will provide a platform for those engaged in nanomedicine research to establish potential collaborations. Some of the keynote speakers and their topics include:
Professor of pathology, Tumor Growth, Invasion, and Metastasis Program at the Moores Cancer Center UCSD Medical Center
“Nanoparticle-mediated targeted drug delivery to the tumor vasculature“
Dane and Mary Louise Miller Endowed Chair in Biomedical Engineering
Director of NIH Nanomedicine Development Center
Cincinnati University College of Medicine
“Instrumentation and metrology for single molecule counting in nanoparticles by a customized single molecule dual-view“
Jean M.J. FrÃ©chet
Professor of Chemistry and Chemical Engineering, Rapoport Chair of Organic Chemistry
University of California, Berkeley and Director of the Organic Nanostructures Facility, The Molecular Foundry, Lawrence Berkeley National Laboratory
“Dendrimers for the conjugation of small molecule drugs“
AANM is a professional, academic and medical society dedicated to advancing research in nanomedicine. Fore more information about AANM, meeting registration, or membership, go to http://www.aananomed.org/.
To learn more about nanomedicine visit our Q&A: The Nanomedicine Future, an interview conducted last year with Chairman of AANM Chiming Wei, MD, PhD, Associate Professor in the department of Surgery at Johns Hopkins University and an Institute for NanoBioTechnology faculty member.